IM Cannabis (IMCC) Retained Earnings (2019 - 2026)
IM Cannabis' (IMCC) quarterly Retained Earnings came in at -$198.6 million in Q1 2026, down 10.2% year-on-year from -$221.2 million in Q1 2025, and down 2.51% quarter-over-quarter from -$193.8 million in Q4 2025.
IM Cannabis (IMCC) Retained Earnings (2019 - 2026) Analysis & Trends
IM Cannabis' Retained Earnings history runs 8 years deep, the most recent figure standing at -$198.6 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 10.2% year-over-year to -$198.6 million in Q1 2026; TTM through Mar 2026 was -$198.6 million, a 10.2% decrease from a year earlier, with the FY2025 full-year figure at -$193.8 million, down 2.45% from the prior year.
- Retained Earnings retreated to -$198.6 million in Q1 2026 per IMCC's latest filing, from -$193.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$47.5 million in Q1 2022 and bottomed at -$198.6 million in Q1 2026.
- The 5-year median for Retained Earnings is -$183.3 million (2023), against an average of -$169.0 million.
- Across the five-year window, Retained Earnings slumped 426.57% in 2022 and rose 4.91% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$176.5 million in 2022, then fell by 3.69% to -$183.0 million in 2023, then slipped by 1.29% to -$185.4 million in 2024, then slipped by 4.53% to -$193.8 million in 2025, then dropped by 2.51% to -$198.6 million in 2026.
- Per Business Quant, the three latest IMCC Retained Earnings figures stand at -$198.6 million (Q1 2026), -$193.8 million (Q4 2025), and -$190.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | -198.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -198.62 Mn |
| Dec 31, 2025 | -193.76 Mn |
| Sep 30, 2025 | -190.80 Mn |
| Jun 30, 2025 | -186.87 Mn |
| Mar 31, 2025 | -180.24 Mn |
| Dec 31, 2024 | -185.36 Mn |
| Sep 30, 2024 | -190.15 Mn |
| Jun 30, 2024 | -188.98 Mn |
| Mar 31, 2024 | -189.56 Mn |
| Dec 31, 2023 | -183.01 Mn |
| Sep 30, 2023 | -183.31 Mn |
| Jun 30, 2023 | -181.35 Mn |
| Mar 31, 2023 | -176.96 Mn |
| Dec 31, 2022 | -176.49 Mn |
| Sep 30, 2022 | -158.41 Mn |
| Jun 30, 2022 | -61.85 Mn |
| Mar 31, 2022 | -47.52 Mn |
| Dec 31, 2021 | -40.26 Mn |
| Sep 30, 2021 | -30.08 Mn |
| Dec 31, 2020 | -25.31 Mn |